The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here ...

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

The FDA has used separate emergency powers to authorize the Pfizer, Moderna, Johnson & Johnson and Novavax vaccines.

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

The CDC and FDA announced ... the new Pfizer-BioNTech bivalent Covid-19 vaccine and strokes in people aged 65 and over, but said they were continuing to recommend the shots. The surveillance ...

The FDA’s vaccine committee is set to consider a recommendation for an annual COVID-19 immunization plan, similar to the one ...

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

The Food and Drug Administration's proposal was outlined in its briefing documents ahead of a meeting of its panel of ...

Booster shots over the winter were "bivalent ... use of current COVID-19 vaccines, and if it is the moment to implement a more routine approach to periodically updating the strain composition," Dr.